Dexcom (DXCM) Treasury Shares (2011 - 2026)

Dexcom (DXCM) has 9 years of Treasury Shares data on file, last reported at $2.1 billion in Q1 2026.

• On a quarterly basis, Treasury Shares rose 34.11% year-over-year to $2.1 billion in Q1 2026; TTM through Mar 2026 was $2.1 billion, a 34.11% increase from a year earlier, with the FY2025 full-year figure at $2.1 billion, up 31.85% from the prior year.
• Treasury Shares for Q1 2026 stood at $2.1 billion, up from $2.1 billion in the prior quarter.
• Over the last five years, Treasury Shares for DXCM reached as high as $26.4 million in Q1 2026 and fell as low as $100000.0 in Q1 2022.
• Historically, Treasury Shares has averaged $12.6 million across 5 years, with a median of $12.4 million in 2024.
• Across the five-year window, Treasury Shares sank 62.7% in 2022 and jumped 2002.14% in 2023, its largest moves.
• Year by year, Treasury Shares stood at $595.0 million in 2022, then soared by 311.95% to $2.5 billion in 2023, then tumbled by 35.49% to $1.6 billion in 2024, then jumped by 31.85% to $2.1 billion in 2025, then gained by 1.72% to $2.1 billion in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $2.1 billion in Q1 2026, $2.1 billion in Q4 2025, and $1.8 billion in Q3 2025.